PAVmed PAVM
NASDAQ PAVM
$5.18 +0.08 (+1.57%)
At close: Aug 20, 2026 · 4:00 PM EDT

PAVmed (PAVM) Acquisitions (2021 - 2022)

PAVmed (PAVM) posted quarterly Acquisitions of $1.0 million for Q3 2022, up 900.0% year-over-year from $100000.0 in Q3 2021, and down 52.38% quarter-over-quarter from $2.1 million in Q4 2021.

PAVmed (PAVM) Acquisitions (2021 - 2022) Analysis & Trends

PAVmed's Acquisitions history runs 2 years deep, the most recent figure standing at $1.0 million for Q3 2022.

  • In Q3 2022, Acquisitions rose 900.0% year-over-year to $1.0 million; the TTM figure through Dec 2022 stood at $3.2 million (changed N/A YoY), while the FY2022 annual figure was $3.2 million, up 42.41% from the prior year.
  • Acquisitions for Q3 2022 stood at $1.0 million, down from $2.1 million in the prior quarter.
  • The five-year high for Acquisitions was $2.1 million in Q4 2021, with the low at $100000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 437.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -4.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -3.49 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 16.00 Mn
10 PAVmed 32.48 Mn 28.69 Mn -89,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2022 1.00 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 100,000.00